Novo Nordisk (Ozempic)

0.549 - 43.669 Ben Gilbert

All right, first episode back. Let's see if I can do this sleep deprived. Oh, you and me both, man. Welcome to Season 14, Episode 1 of Acquired, the podcast about great companies and the stories and playbooks behind them. I'm Ben Gilbert. I'm David Rosenthal. And we are your hosts. Today's episode is on the company behind these sensational diabetes and weight loss drugs, Ozempic and WeGoVie.